Literature DB >> 9827549

Intestinal absorption of luteolin and luteolin 7-O-beta-glucoside in rats and humans.

K Shimoi1, H Okada, M Furugori, T Goda, S Takase, M Suzuki, Y Hara, H Yamamoto, N Kinae.   

Abstract

In this study, we investigated the intestinal absorption of luteolin and luteolin 7-O-beta-glucoside in rats by HPLC. The absorption analysis using rat everted small intestine demonstrated that luteolin was converted to glucuronides during passing through the intestinal mucosa and that luteolin 7-O-beta-glucoside was absorbed after hydrolysis to luteolin. Free luteolin, its conjugates and methylated conjugates were present in rat plasma after dosing. This suggests that some luteolin can escape the intestinal conjugation and the hepatic sulfation/methylation. LC/MS analysis showed that the main conjugate which circulates in the blood was a monoglucuronide of the unchanged aglycone. Luteolin in propyleneglycol was absorbed more rapidly than that in 0.5% carboxymethyl cellulose. The plasma concentration of luteolin and its conjugates reached the highest level 15 min and 30 min after dosing with luteolin in propyleneglycol, respectively. HPLC analysis also allowed us to demonstrate the presence of free luteolin and its monoglucuronide in human serum after ingestion of luteolin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9827549     DOI: 10.1016/s0014-5793(98)01304-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  59 in total

1.  Luteolin inhibits microglia and alters hippocampal-dependent spatial working memory in aged mice.

Authors:  Saebyeol Jang; Ryan N Dilger; Rodney W Johnson
Journal:  J Nutr       Date:  2010-08-04       Impact factor: 4.798

2.  Luteolin prevents LPS-induced TNF-α expression in cardiac myocytes through inhibiting NF-κB signaling pathway.

Authors:  Lihua Lv; Linhua Lv; Yubi Zhang; Qiuhuan Kong
Journal:  Inflammation       Date:  2011-12       Impact factor: 4.092

3.  Identification of the Flavonoid Luteolin as a Repressor of the Transcription Factor Hepatocyte Nuclear Factor 4α.

Authors:  Juan Li; Jun Inoue; Jung-Min Choi; Shugo Nakamura; Zhen Yan; Shinya Fushinobu; Haruhiko Kamada; Hisanori Kato; Tsutomu Hashidume; Makoto Shimizu; Ryuichiro Sato
Journal:  J Biol Chem       Date:  2015-08-13       Impact factor: 5.157

4.  Inhibition of diethylnitrosamine-initiated alcohol-promoted hepatic inflammation and precancerous lesions by flavonoid luteolin is associated with increased sirtuin 1 activity in mice.

Authors:  Bruna Paola Murino Rafacho; Camilla Peach Stice; Chun Liu; Andrew S Greenberg; Lynne M Ausman; Xiang-Dong Wang
Journal:  Hepatobiliary Surg Nutr       Date:  2015-04       Impact factor: 7.293

5.  Luteolin Could Improve Cognitive Dysfunction by Inhibiting Neuroinflammation.

Authors:  Zhao-Hui Yao; Xiao-Li Yao; Yong Zhang; Shao-Feng Zhang; Ji-Chang Hu
Journal:  Neurochem Res       Date:  2018-02-01       Impact factor: 3.996

6.  Breast cancer resistance protein-mediated efflux of luteolin glucuronides in HeLa cells overexpressing UDP-glucuronosyltransferase 1A9.

Authors:  Lan Tang; Ye Li; Wei-Ying Chen; Shan Zeng; Ling-Na Dong; Xiao-Juan Peng; Wen Jiang; Ming Hu; Zhong-Qiu Liu
Journal:  Pharm Res       Date:  2013-10-03       Impact factor: 4.200

Review 7.  Luteolin, a flavonoid with potential for cancer prevention and therapy.

Authors:  Yong Lin; Ranxin Shi; Xia Wang; Han-Ming Shen
Journal:  Curr Cancer Drug Targets       Date:  2008-11       Impact factor: 3.428

8.  Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites.

Authors:  Jeremy P E Spencer; Gunter G C Kuhnle; Robert J Williams; Catherine Rice-Evans
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

9.  Flavonoid-mediated presenilin-1 phosphorylation reduces Alzheimer's disease beta-amyloid production.

Authors:  Kavon Rezai-Zadeh; R Douglas Shytle; Yun Bai; Jun Tian; Huayan Hou; Takashi Mori; Jin Zeng; Demian Obregon; Terrence Town; Jun Tan
Journal:  J Cell Mol Med       Date:  2008-04-09       Impact factor: 5.310

10.  Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype.

Authors:  Konstantin Dirscherl; Marcus Karlstetter; Stefanie Ebert; Dominik Kraus; Julia Hlawatsch; Yana Walczak; Christoph Moehle; Rudolf Fuchshofer; Thomas Langmann
Journal:  J Neuroinflammation       Date:  2010-01-14       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.